Congratulations!
Welcome to Breakthrough Technology Profits

 

Dear Reader,

I’m Joe Duarte, M.D., and I want to thank you for viewing my presentation today.

In addition, I want to say “Congratulations” on your decision to join my publication, Breakthrough Technology Profits .

You’ve just secured a dominant edge in the world’s most lucrative investing sector: technology.

As I explained in my presentation, biotech has likely created more millionaires and billionaires than any other sector in history.

It’s also generated trades like Amgen that turned every $1,000 into $1.78 million in a relatively short time span.

But the money about to be made on this cancer vaccine breakthrough could DWARF it all.

Cancer currently generates $91 billion every year for chemo, radiation, and surgery. And that number is projected to nearly double.

But if results from clinical trials at institutions like Stanford, Duke, and John Hopkins are even half-right… this cancer vaccine will make current cancer care OBSOLETE the second it hits the market.

The tiny company that owns all the patents on this development trades for a fraction of what my models are predicting.

If it grabs a fraction of the money spent on kidney cancer treatment alone – and it’s poised to take a whole lot more – it could trade for well over $136.

We’re talking about potential gains of 2,700%… and that’s just before 2016 is over.

Because this cancer breakthrough is so vital for so many lives…

The FDA has already granted this treatment a rare legal designation that virtually guarantees approval.

Six countries worldwide – including England and Germany – have already approved it… and it’s right now entering hospitals around the world.

When the final phase of clinical trials ends, the FDA is set to quickly follow their lead – unleashing the first wave of massive profits.

Investors who buy in now could see the biggest windfall of 2016 – and even their lives…

All while helping support a vital life-saving treatment for 14 million cancer sufferers.

To help you get in on the ground floor quickly, I’ve put together a resource package detailing everything you need to know about this incredibly lucrative and urgent medical opportunity.

Just take a look at everything you get today:

One Little Shot to Kill Cancer Dead:
27 Times Your Money on the “Alpha Cells” Discovery

This briefing contains not one, not two, but three explosive opportunities:

• "Alpha Cells" Play #1: Breakthrough medical technology sparks new cancer biotech revolution!
  If you could only own one cancer therapy company for the next 10 years, this would be the one. This company has been on the cutting edge of the “Alpha Cells” discovery from the very beginning. Its founders even include the scientist who discovered and won the Nobel Prize for his cancer breakthrough. Already, scientists at Duke, John Hopkins, Stanford, and UCLA have testified to its cancer-killing power. Again and again, over 1,065 independent studies have confirmed that its “cancer vaccine” can destroy just about any type of cancer – without dangerous side effects. That’s why the FDA passed a special legal ruling for this company’s “Alpha Cells” treatment... one that’s helped it sail through clinical trials right to the FDA’s doorstep. Other companies that have received this special ruling, like Amgen, have surged for 178,800% gains. And this opportunity could be no different. When its final phase of trials reaches its close, a critical announcement could send shares surging overnight from $10... to $50... to $136. Good enough to turn every $10,000 into $270,000 before 2016 is over, and that’s just the beginning!

• "Alpha Cells" Play #2: This tiny company could be the target of a $10 billion buyout!
  This company is on the radar of every Big Pharma company scrambling for a major edge in the cancer immunotherapy market. Hedge-fund managers claim a buyout could amount to a staggering $10 billion... equal to over 7 times its market cap. Why would they pay so much? Its cutting-edge technology is now shaping up to be a major player in the CAR-T immunotherapy market.In essence, it genetically programs our immune system’s T-Cell warriors to directly attack cancer cells.The real kicker is its safety mechanism, which “turns off” T-Cells to avoid damage to healthy cells.It’s so impressive, in fact, that MD Anderson Cancer Center – the world’s leading cancer research hospital – has signed a deal to employ this technology.The president of the hospital even says it “represents one of the most exciting approaches with curative potential in oncology today.”With a stunning portfolio of patents, this company is an innovative leader light-years ahead of the competition. DO NOT WAIT for the coming buyout. By then, the stock could be sitting on gains as high as 542%. Get in now!

• "Alpha Cells" Play #3: Triple your money on the Big Pharma of immunotherapy. 
  My final play only recently IPO’d, but in a short time it’s become the Big Pharma of cancer immunotherapy.While it’s much bigger and trades for more than the first two plays I mentioned, there’s still TONS of upside.The results of one clinical trial on its therapy for leukemia boosted patient survival rate 9 times over!Results like these have Big Pharma scrambling to cut deals.One pharmaceutical giant recently inked a $1 billion licensing deal with this company – the largest upfront sum EVER for a biotech agreement.The deal alone values the shares at around $94, a 75% return on current value.What’s more, it’s got a war chest that almost every biotech startup would envy.That’s how it’s managed to grab large shares of the explosive immuno-oncology market – scooping up tinier companies patents and assets. A buyout for one or both of the first plays in this report is not out of the question.Based on the current value of assets and cash on hand – plus upcoming clinical trial dates – my research shows that this new “Big Pharma of immunotherapy” could triple your money within 2016.

This investor briefing is only a small part of what you’ll get as a new member of Breakthrough Technology Profits.

I’ve spent decades building a network in the medical field, including some of the top physicians who have conducted clinical trials on some of the biggest medical breakthroughs ever developed.

That includes frontier medical fields like genetic editing and brand-new stem-cell therapies.

All of this means you have full access to my insider knowledge on some of the medical field’s most cutting-edge developments.

It also means you’ll know the difference between so-called “breakthroughs” that are just full of hot air and hype…

And the real-deal technology and treatments that actually work… and have a real shot at making it to market.

I’ll take you through my 5-criteria formula for identifying ground-floor biotech opportunities that could surge for over 1,000% gains.

This is how I can ensure you a reliable, consistent stream of life-changing profit opportunities, again and again.

But remember, medical technology is only part of what we do here at Breakthrough Technology Profits.

From cutting-edge tech breakthroughs in the cybersecurity sector… to exoskeleton technology that recently handed our readers the opportunity for 150% gains in two days…

We dig deep to uncover the ground-floor tech opportunities emerging now – the kind that mint millionaires.

As a member of Breakthrough Technology Profits, you’ll get access to fast-moving double-digit and triple-digit opportunities we’ve recently shown our readers, like:

• 150% on Rewalk Robotics in 2 days
• 142% on Ebix in 11 months
• 114% on Paycom Software in 10 months
• 81% on Silicon Motion Technology Corp in 12 months
• 41% on FireEye in 6 months
• 39% on Gigamon in only 5 weeks

I’m proud of these successes. But they pale in comparison to the opportunity coming down the pike right now.

And remember, my position at the heart of the biotech market gives me access to knowledge and opportunities most people never lay eyes on.

I’m talking about unique opportunities hidden in the nooks and crannies of the medical market.

These are the kinds of opportunities that are discussed behind closed doors, in boardrooms and scientific institutions.

These are the kinds of opportunities that unfold in the shadows of the world’s pharma titans. Most importantly: These are the kinds of plays that can create tremendous riches very quickly.

As a member of Breakthrough Technology Profits, you’ll be right by my side, getting a “first look” chance to turn these breaking situations into massive gains.

Let me show you everything your Breakthrough Technology Profits membership includes:

• MONTHLY BRIEFINGS – Sent directly to your inbox so you can act on them quickly, these alerts will give you my exact recommendations for making money on big breakthroughs wherever the opportunities are.
• WEEKLY MARKET UPDATES – Every week, you’ll get my summary of where the tech markets are now, and where they’re headed. Plus my insights on emerging shifts and trends in technology you could play for triple-digit short-term wins...
• SPECIAL RESEARCH REPORTS – Released periodically as we write them, these reports cover especially timely or relevant big-picture themes.
• 24/7 WEB RESOURCE ACCESS – Your unique password is the key to accessing all of my past and current Action Alerts, plus my Weekly Updates, Special Research Reports, recommendations, FAQs, and Reader’s Forum.

Now, you’re probably wondering: How much is a resource like this worth?

Some industry insiders tell me that a full year of Breakthrough Technology Profits is easily worth $5,000. Some even feel $7,500 per year is more commensurate with the full Breakthrough Technology Profits value.

And when we asked some of our readers, they insisted that at $10,000 a year, Breakthrough Technology Profits would PAY FOR ITSELF many times over!

But don’t worry, you’re not going to pay anywhere near that.

Normally, Breakthrough Technology Profits has a price of $3,000. And that’s a deep bargain considering everything you get, including:

• Special Investor Briefing: One Little Shot to Kill Cancer Dead: 27 Times Your Money on the “Alpha Cells” Discovery
• Monthly Breakthrough Technology Profits intelligence briefings
• Breakthrough Technology Profits weekly market updates
• Breakthrough Technology Profits special research reports
• 24/7 access to the Breakthrough Technology Profits members’ website

The tiny company alone is positioned to turn every $10,000 into $270,000. And you get its information for free – no strings attached! – when you give Breakthrough Technology Profits a try.

Again, given everything you get, plus the urgent special reports, $3,000 is an exceptional value.

Today, you can become a member
for only $1,495!
(A 50% savings!)

If you decide Breakthrough Technology Profits is right for you, then great!

For the next two months you can secure a stake in this tiny “Alpha Cells” company and every other opportunity I share with you.

You’ll be granted unrestricted access to all of my weekly analysis, reports, audio/video briefings — as well as the Breakthrough Technology Profits members’ website and portfolios.

Plus you can utilize the private stock discussion board I’ve made available to you.

If for any reason during your first 60 days you feel this isn’t a good fit, simply contact me – or any member of my team – and I’ll quickly refund every penny of your subscription.

That protects you in the short term.

But I also want to make sure you’re covered during your entire one-year membership.

And that’s why there’s also…

Guarantee #2:

Six Triple-Digit Winners in the Next 12 Months…

Or I’ll work for free

If we don’t provide you at least six triple-digit winners in the next 12 months – give us a call and I will extend your membership to Breakthrough Technology Profits another year on the house.

So if we only provide 5 triple-digit opportunities…

I will work for free for you… and my entire team will work for free as well.

Because 5 triple-digit winners is less than 6 triple-digit winners.That’s how confident I am that Breakthrough Technology Profits can change your fortunes.

I think you’ll agree: That’s as fair as it gets.

Go ahead, dive in. Enjoy yourself. And pay very close attention to the urgent recommendations I’m making today, especially the tiny company at the center of it all.

Folks who get in now, on the ground floor, could see 27 times their money. And that’s just the beginning…

Remember, the biotech sector has produced trades big enough to turn $1,000 into $1.78 million.

But you need to move fast. At this moment, this tiny company is preparing a critical announcement that could make the stock go vertical. Insiders are loading up on shares in anticipation. You simply can’t wait.

Remember, even if you decide to cancel your subscription for a full refund, you keep everything, including the special briefing.

You have absolutely nothing to lose! Please don’t miss out. Only 200 people today will get all this at an amazingly low price. So act now.

Sincerely,

Joe Duarte, M.D

If you prefer to order over the phone, our customer service team is available at (800) 832-2330